Kaoru Tohyama

2.8k total citations
121 papers, 1.9k citations indexed

About

Kaoru Tohyama is a scholar working on Hematology, Molecular Biology and Immunology. According to data from OpenAlex, Kaoru Tohyama has authored 121 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Hematology, 50 papers in Molecular Biology and 22 papers in Immunology. Recurrent topics in Kaoru Tohyama's work include Acute Myeloid Leukemia Research (48 papers), Epigenetics and DNA Methylation (11 papers) and Cell Adhesion Molecules Research (11 papers). Kaoru Tohyama is often cited by papers focused on Acute Myeloid Leukemia Research (48 papers), Epigenetics and DNA Methylation (11 papers) and Cell Adhesion Molecules Research (11 papers). Kaoru Tohyama collaborates with scholars based in Japan, United States and China. Kaoru Tohyama's co-authors include Yumi Tohyama, Keisuke Kawakami, K. Chiba, Yataro Yoshida, Hirohei Yamamura, Takayuki Tsujioka, Jinsong He, Chisato Tanaka, Toshinori Kondo and Takashi Uchiyama and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and The EMBO Journal.

In The Last Decade

Kaoru Tohyama

118 papers receiving 1.9k citations

Peers

Countries citing papers authored by Kaoru Tohyama

Since Specialization

Citations

This map shows the geographic impact of Kaoru Tohyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaoru Tohyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaoru Tohyama more than expected).

Fields of papers citing papers by Kaoru Tohyama

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kaoru Tohyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaoru Tohyama. The network helps show where Kaoru Tohyama may publish in the future.

Co-authorship network of co-authors of Kaoru Tohyama

This figure shows the co-authorship network connecting the top 25 collaborators of Kaoru Tohyama. A scholar is included among the top collaborators of Kaoru Tohyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kaoru Tohyama. Kaoru Tohyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Histone deacetylase inhibitor, panobinostat, exerts anti-proliferative effect with partial normalization from aberrant epigenetic states on granulosa cell tumor cell lines 2022 ·PLoS ONE ·(unknown), Takayuki Tsujioka, Akira Kitanaka, Kaoru Tohyama, (unknown)	1
2	Expert consensus regarding standardization of sample preparation for clotting time assays 2020 ·International Journal of Hematology ·Masahiro Ieko, Yutaka Komiyama, Satoshi Yamazaki, (unknown), (unknown), (unknown), Masato Matsuda, (unknown), (unknown), (unknown), Osamu Kumano, (unknown), Tsutomu Yoshida, (unknown), (unknown), Tetsuji Yamashita, (unknown), (unknown), Yohko Kawai, Kaoru Tohyama, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	6
3	Menatetrenone facilitates hematopoietic cell generation in a manner that is dependent on human bone marrow mesenchymal stromal/stem cells 2020 ·International Journal of Hematology ·(unknown), (unknown), Sumie Fujii, Taira Maekawa, Akira Andoh, Kaoru Tohyama, Akifumi Takaori‐Kondo, Yasuo Miura	5
4	An MDS-derived cell line and a series of its sublines serve as an in vitro model for the leukemic evolution of MDS 2018 ·Leukemia ·(unknown), Takayuki Tsujioka, (unknown), Shuichiro Okamoto, (unknown), (unknown), Takahiro Yamauchi, Akira Kitanaka, Yumi Tohyama, Kaoru Tohyama	12
5	β-Catenin Is a Candidate Therapeutic Target for Myeloid Neoplasms with del(5q) 2017 ·Cancer Research ·Liping Li, Yue Sheng, Wenshu Li, Chao Hu, Nupur Mittal, Kaoru Tohyama, (unknown), You‐Yang Zhao, Howard Ozer, Tongyu Zhu, Zhijian Qian	17
6	Approach to New Therapeutics: Investigation by the Use of MDS-derived Cell Lines 2012 ·Current Pharmaceutical Design ·Takayuki Tsujioka, (unknown), Yumi Tohyama, Kaoru Tohyama	3
7	Rab27b regulates c-kit expression by controlling the secretion of stem cell factor 2012 ·Biochemical and Biophysical Research Communications ·Chisato Tanaka, (unknown), Jinsong He, (unknown), (unknown), (unknown), Takayuki Tsujioka, Kaoru Tohyama, Hirohei Yamamura, Hisahide Nishio, Yumi Tohyama	6
8	The impact of serum soluble interleukin-2 receptor levels on the diagnosis of malignant lymphoma 2011 ·Takayuki Tsujioka, (unknown), Toshinori Kondo, (unknown), Taizo Tasaka, Takashi Sugihara, Hideho Wada, Kaoru Tohyama	5
9	Genome-wide identification of human microRNAs located in leukemia-associated genomic alterations 2010 ·Blood ·Daniel T. Starczynowski, Ryan D. Morin, Andrew McPherson, Jeff Y. L. Lam, Raj Chari, Joanna Węgrzyn, Florian Kuchenbauer, Martin Hirst, Kaoru Tohyama, R. Keith Humphries, Wan L. Lam, Marco A. Marra, Aly Karsan	94
10	Multicenter phase II trial of vitamin K2 monotherapy and vitamin K2 plus 1α-hydroxyvitamin D3 combination therapy for low-risk myelodysplastic syndromes 2010 ·Leukemia Research ·Nobu Akiyama, Keisuke Miyazawa, Yoshinobu Kanda, Kaoru Tohyama, Mitsuhiro Omine, Kinuko Mitani, Kazuma Ohyashiki	17
11	Philadelphia chromosome-positive acute myeloid leukemia (Ph+AML) treated with imatinib mesylate (IM) 2009 ·Leukemia Research ·Toshinori Kondo, Taizo Tasaka, (unknown), (unknown), Yasutaka Kubo, Yoshiko Matsuhashi, (unknown), Yoshito Sadahira, Hideho Wada, Takashi Sugihara, Kaoru Tohyama	13
12	Lenalidomide is active in Japanese patients with symptomatic anemia in low- or intermediate-1 risk myelodysplastic syndromes with a deletion 5q abnormality 2009 ·International Journal of Hematology ·Hironori Harada, Mitsumasa Watanabe, Kenshi Suzuki, Soshi Yanagita, Takahiro Suzuki, Yataro Yoshida, Akiro Kimura, Mitsuru Tsudo, Akira Matsuda, Kaoru Tohyama, Masafumi Taniwaki, Kenichi Takeshita, Masaaki Takatoku, Keiya Ozawa	13
13	Myelodysplastic syndrome with chromosome 5 abnormalities: a nationwide survey in Japan 2008 ·Leukemia ·Taizo Tasaka, Kaoru Tohyama, (unknown), Kazuma Ohyashiki, Kinuko Mitani, T Hotta, A Kanamaru, Shinichiro Okamoto, (unknown), A Kimura, Masao Tomonaga, Takashi Uchiyama, K Ozawa, (unknown)	17
14	A Prospective Study of Cyclosporine A Treatment of Patients with Low-Risk Myelodysplastic Syndrome: Presence of CD55-CD59- Blood Cells Predicts Platelet Response 2007 ·International Journal of Hematology ·Takayuki Ishikawa, Kaoru Tohyama, Shinji Nakao, Yataro Yoshida, Masanao Teramura, Toshiko Motoji, Masaaki Takatoku, Mineo Kurokawa, Kinuko Mitani, Takashi Uchiyama, Mitsuhiro Omine	16
15	Improved detection of minimal acute myeloid leukemia cells by the use of the combined parameters of XE‐2100 hematology analyzer 2005 ·Cytometry Part B Clinical Cytometry ·Kaoru Tohyama, (unknown), (unknown), Kinya Uchihashi, (unknown), Keiko Takahashi, (unknown), Satoshi Ichiyama, Yukio Hamaguchi	2
16	Cyclosporin A therapy for patients with myelodysplastic syndrome: multicenter pilot studies in Japan 2003 ·Leukemia Research ·Takashi Shimamoto, Kaoru Tohyama, Takahiro Okamoto, Takashi Uchiyama, Hiroyuki Mori, Masao Tomonaga, Yoshinobu Asano, Yoshiyuki Niho, Masanao Teramura, Hideaki Mizoguchi, Mitsuhiro Omine, Kazuma Ohyashiki	49
17	Retrovirus-mediated gene transfer of granulocyte colony-stimulating factor receptor (G-CSFR) cDNA into MDS cells and induction of their differentiation by G-CSF 2000 ·PubMed ·Satoki Nakamura, Kazunori Ohnishi, Hitoshi Yoshida, Kaori Shinjo, Akihiro Takeshita, Kaoru Tohyama, Ryuzo Ohno, Yukio Koide	17
18	Vitamin K2 and its derivatives induce apoptosis in leukemia cells and enhance the effect of all-trans retinoic acid 1997 ·Leukemia ·Makoto Yaguchi, Keisuke Miyazawa, (unknown), J Nishimaki, Masahiro Kizaki, Kaoru Tohyama, (unknown)	63
19	Production of Multiple Growth Factors by a Newly Established Human Thyroid Carcinoma Cell Line 1992 ·Japanese Journal of Cancer Research ·Kaoru Tohyama, Yataro Yoshida, (unknown), Emiko Sano, Hisataka Kobayashi, Keigo Endo, Masanobu Naruto, Tõru Nakamura	29
20	Different stromal cell lines support lineage-selective differentiation of the multipotential bone marrow stem cell clone LyD9. 1991 ·The Journal of Experimental Medicine ·KK Lee, Tatsuo Kinashi, Kaoru Tohyama, Kei Tashiro, (unknown), (unknown), Tasuku Honjo	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact